← Evidence map

ArticleSurgical neurology international2022

Timing of bevacizumab administration after biopsy for unresectable newly diagnosed glioblastoma.

Masahide Matsuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36600767